Opportunity for Physician Educators to Join Binaytara Foundation’s Education Academy

Oncologists Interested in Improving Access to Cancer Care Encouraged to Apply

Are you an oncologist who is passionate about educating fellow providers? We invite you to apply to join the Binaytara Foundation Education Academy! Members will be involved in the planning and implementation of the educational activities of the Foundation, including Hematology/Oncology meetings, the International Journal of Cancer Care & Delivery (IJCCD), and the educational game. Our Education Academy Chairs, Drs. Sid Yadav and Sri Tantravahi, have formed the following subcommittees:

  • Breast Cancer
  • GI Cancer
  • Thoracic Cancer
  • GU Cancer
  • GYN Cancer
  • Hematological Malignancies
  • General Oncology
  • Tumor Board
  • Residents and Fellows

To apply, please email btf.office@binayfoundation.org with your CV and a letter expressing your area of interest. 

Terms and responsibilities:

  1. The commitment will be a one-year term
  2. Education academy meetings will occur every three months. Members are expected to attend at least 50% of the meetings
  3. Each subcommittee will be expected to submit at least one article to the IJCCD each year

Binaytara Foundation (BTF) is a global cancer non-profit committed to minimizing cancer disparities through education, advocacy, and innovation. Our projects include a multi-channel hematology and oncology education program focused on educating healthcare providers and cancer patients about the most recent advances in cancer care and a global oncology program focused on developing sustainable cancer programs and services in resource-poor communities.

BTF Education Academy members are instrumental in achieving our goal of improving access to cancer care. Your participation will have an impact for years to come. Apply today!

Staff Writer - The Cancer News

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

6 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

6 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

6 months ago